The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Post Kenvue spin, the company is deciding to use cash to further diversify their MedTech offerings. Explore more details here ...

Johnson, a Louisiana Republican, met with Trump on Thursday as the House leader looks for a path forward to funding the ...

House Speaker Mike Johnson (R-La.) in an interview with The Hill offered his thoughts on artificial intelligence (AI) and ...

WASHINGTON — House Speaker Mike Johnson knocked “Comrade Kamala” Harris on Tuesday for touting “centralized price controls” ...

We recently compiled a list of the 10 Best Beauty Stocks To Buy According to Short Sellers. In this article, we are going to ...

After a seven-year legal battle, the National Consumer Dispute Redressal Commission (NCDRC) has delivered an its judgment in the case of businessman Purshottam Lohia versus Johnson & Johnson Ltd.

After a more than six-hour council meeting that stretched past midnight, a majority of Lenexa City Council rejected the plan ...